Funded Tech Companies

Ilkos Therapeutics

Researching who backed Ilkos Therapeutics? CTI Life Sciences Fund, Fonds de solidarite FTQ and private investors joined the equity holders in this innovative biopharmaceutical company.

Company Overview

Company Name
Ilkos Therapeutics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
Undisclosed
Laval QC, H7M 1B2
Canada
Phone
Undisclosed
Website
Email Address
Not Recorded

Company Background Information

Overview
The creation of ILKOS THERAPEUTICS will make it possible to continue the clinical development of an innovative drug, which was deprioritized from Servier's R&D strategic priorities. This innovative project reflects the evolution of our business model.
Profile
Ilkos Therapeutics LinkedIn Company Profile
Social Media
Ilkos Therapeutics Company Twitter Account
Company News
Ilkos Therapeutics News
Facebook
Ilkos Therapeutics on Facebook
YouTube
Ilkos Therapeutics on YouTube
Last Transaction
9/30/2016

Financing History

Date
Type
Amount
Venture Equity
$21,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Mark Beaudet
  Mark Beaudet LinkedIn Profile  Mark Beaudet Twitter Account  Mark Beaudet News  Mark Beaudet on Facebook


Company Investors

  • CTI Life Sciences Fund (Jean-François Leprince)
  • Fonds de solidarite FTQ (Danny Gagné)
  • Private Investors (Frédéric Fasano)

 

 

 

Browse more funded tech companies:

iLike | Illumagear

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary